Overview
Nathalie Auger practices practicing medicine in Villejuif, France.
Ms. Auger is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Prolymphocytic Leukemia, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Leukemia.
She is actively involved in clinical research, co-authoring 62 peer reviewed articles.
Gender
Locations
Villejuif, 94805, France
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Nathalie Auger
Is Nathalie Auger a top-rated expert for Prolymphocytic Leukemia?
MediFind is an objective health platform that identifies experts based on real-world data. Nathalie Auger is classified as an Advanced expert for Prolymphocytic Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Nathalie Auger participate in research or clinical trials?
Yes. Nathalie Auger has published 62 articles and abstracts on conditions like Prolymphocytic Leukemia. You can view a list of Nathalie Auger's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung CancerMs. Auger isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Prolymphocytic LeukemiaMs. Auger isAdvanced. Learn about Prolymphocytic Leukemia.
- Experienced
- Acute Myeloid Leukemia (AML)Ms. Auger isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AnemiaMs. Auger isExperienced. Learn about Anemia.
- Aplastic AnemiaMs. Auger isExperienced. Learn about Aplastic Anemia.
- Ataxia-TelangiectasiaMs. Auger isExperienced. Learn about Ataxia-Telangiectasia.
- Breast CancerMs. Auger isExperienced. Learn about Breast Cancer.
- Chromosome 8p DeletionMs. Auger isExperienced. Learn about Chromosome 8p Deletion.
- Chronic B-Cell Leukemia (CBCL)Ms. Auger isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Ms. Auger isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Congenital Aplastic AnemiaMs. Auger isExperienced. Learn about Congenital Aplastic Anemia.
- Embryonal Tumor with Multilayered Rosettes
- Fanconi AnemiaMs. Auger isExperienced. Learn about Fanconi Anemia.
- Gliomatosis CerebriMs. Auger isExperienced. Learn about Gliomatosis Cerebri.
- LeukemiaMs. Auger isExperienced. Learn about Leukemia.
- Mosaic Trisomy 8Ms. Auger isExperienced. Learn about Mosaic Trisomy 8.
- Myelodysplastic Syndrome (MDS)Ms. Auger isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- NeuroblastomaMs. Auger isExperienced. Learn about Neuroblastoma.
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Premature Ovarian FailureMs. Auger isExperienced. Learn about Premature Ovarian Failure.
- RhabdomyosarcomaMs. Auger isExperienced. Learn about Rhabdomyosarcoma.
- Small Cell Lung Cancer (SCLC)Ms. Auger isExperienced. Learn about Small Cell Lung Cancer (SCLC).
- Small Lymphocytic Lymphoma (SLL)Ms. Auger isExperienced. Learn about Small Lymphocytic Lymphoma (SLL).
- TelangiectasiaMs. Auger isExperienced. Learn about Telangiectasia.
- Xeroderma PigmentosumMs. Auger isExperienced. Learn about Xeroderma Pigmentosum.